Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Mylan Pharmaceuticals Inc., a Viatris Company with status Current. The shortage was first posted on 07/14/2023.
Shortage Details
- Status
- Current
- Company
- Mylan Pharmaceuticals Inc., a Viatris Company
- Package NDC
- 0378-6855-77
- Dosage Form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77)
- Initial Posting
- 07/14/2023
- Revised Date